Skip to content
Back to meeting Original
UroToday.com· @urotoday · X·· 22 hours agoScore45

cabozantinib

Body · original

Plasma Kidney Injury Molecule-1 Dynamics During First-Line Immunotherapy with or without Cabozantinib in Advanced Renal Cell Carcinoma. Presented by @VincentWenxinXu @DanaFarber. #ESMO26 written coverage by @rksayyid @UAUrology > https://bit.ly/4klZZGi #KidneyCancer #RCC #Immunotherapy @myESMO

86 views · 0 likes · 1 repost · 0 replies

Source: UroToday.com · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.